Rising prevalence of chronic diseases is expected to drive the growth of
global drug delivery devices market
According to TechSci Research report, “Global Drug
Delivery Devices Market By Route of Administration (Oral Drug
Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug
Delivery, Pulmonary Drug Delivery, Others), By Device (Syringes, Inhalers,
Patch Pumps, And Others), By Patient Care Setting (Hospitals, Diagnostic
Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), By
Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes,
Others), By Region, Competition, Forecast & Opportunities, 2025”,
global drug delivery devices market is expected to witness a significant CAGR
during the forecast period. Favorable government regulations all around the
world is one of the major factors contributing to the growth of global drug
delivery devices market. Moreover, growth in the biologics market is expected
to bode well for the growth of global drug delivery devices market through the
forecast period. In addition to this, technological advancements and new
product launches are projected to positively influence the growth of global
drug delivery devices market in the years to come. Also, high growth in the
consumption of drugs and therapeutic pharmaceuticals owing to better nature of
treatment associated with these drugs, is further making headway for the growth
of global drug delivery devices market. However, there are some factors that
might act as major impediments to the growth of global drug delivery devices
market including increase in complications and expertise required in delivering
therapeutics and drugs through these devices.
Browse XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on " Global Drug
Delivery Devices Market "
Global drug delivery devices market can be segmented based on route of
administration, device, patient care setting, application, company, and region.
Considering the patient care setting, the market is fragmented into hospitals,
diagnostic centers, ambulatory surgery centers/clinics, home care settings, and
others. Among these, the hospitals segment dominated the global drug delivery
devices market until 2019 and is further anticipated to maintain its dominance
during the forecast period as well. This high growth can be attributed to
the significant number of inpatient and outpatient visits to hospitals and
requirement of large volumes of drugs and their respective delivery devices to
accommodate to the demand of the large patient pool. In terms of route of
administration, the market can be categorized into oral drug delivery,
injectable drug delivery, topical drug delivery, ocular drug delivery,
pulmonary drug delivery, nasal drug delivery, transmucosal drug delivery, and
implantable drug delivery. Out of these, the injectable drug delivery segment
is forecast to register high growth in the next 5 years which is attributable
to growing demand for biosimilar products, increasing prevalence of chronic
diseases (particularly cancer and diabetes) and CVD, and low cost of devices
and manufacturing.
F. Hoffmann-La Roche Ltd, Antares Pharma, Novartis AG, 3M Company, Sulzer
Ltd, Gerresheimer AG, Sanofi S.A., Johnson & Johnson Services, Inc., Bayer
AG, GlaxoSmithKline plc, Novosanis, MEDMIX SYSTEMS AG, Merck & Co., Inc.,
Pfizer Inc., Insulet Corporation, OraSure Technologies, Inc., West
Pharmaceutical Services, Inc., SMC Ltd., ViVO Smart Medical Devices Ltd., Cipla
Inc, are among others are the leading players operating in global drug delivery
devices market. The players are adopting several growth strategies to enhance
the market scenario of drug delivery devices. Other competitive strategies
include new technological developments; mergers & acquisitions; agreements,
partnerships, and collaborations; and expansions to diverse their product
portfolio in order to strengthen their market position.
download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4953
customers can also request for 10% free customization on this report.
“North America is forecast to dominate the global drug delivery devices
market until 2025 on account of high growth in biologics in the pharmaceuticals
market. Furthermore, presence of key market players in the region is further
anticipated to boost the market growth for drug delivery devices over the
coming years. Additionally, Asia-Pacific region is estimated to register high
growth in the years to come which can be attributed to rise in demand for drug
delivery products from the diabetic population.”, said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“Global Drug Delivery Devices Market By Route of Administration (Oral
Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug
Delivery, Pulmonary Drug Delivery, Others), By Device (Syringes, Inhalers,
Patch Pumps, And Others), By Patient Care Setting (Hospitals, Diagnostic
Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), By
Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes,
Others), By Region, Competition, Forecast & Opportunities, 2025” has
evaluated the future growth potential of global drug delivery devices market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global drug delivery devices market.
Browse Related Reports
Europe Wearable Medical Devices Market By Type (Vital Signs Monitoring
Devices v/s Therapeutic Devices), By Product Type (Activity Monitors/Trackers,
Smartwatches, Patches, Smart Clothing), By Purpose (Heart rate, Blood Pressure,
Body Temperature, Blood oxygen saturation, Posture, Physical Activities,
Hearing Aids, Others), By Site (Handheld, Headband, Strap/Clip/Bracelet, Shoe
Sensors, Others), By Application (General Health & Fitness, Remote Patient
Monitoring, Home Healthcare), By Distribution Channel (Store-Based v/s
Non-Store-Based), By Business Segment (B2B Vs B2C), By Country, Forecast &
Opportunities, 2025
Global Medical Tourism Market By Treatment Type (Cardiovascular
Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment,
Fertility Treatment, Dental Treatment, Cosmetic Treatment, Organ Transplant,
Neuro & Spinal Surgery, ENT Treatment, Others), By Service (Medical VISA,
Appointment Fixation, Treatment/Check-up Packages, Others), By Region, Forecast
& Opportunities, 2025
No comments:
Post a Comment